We are building engagement and impact with the federal and local health authorities, through a scientific dialogue and based on quantitative pharmacometrics
STEP 1: Modeling Sciences Day, Innovation in Pharmaceutics and Healthcare, Nov 2012, First-in-Russia scientific conference dedicated to application of modelling methods for the drug R&D and healthcare
STEP 2: Massive publication in the public and specialized press, e.g. “Vedomosty” and “Kommersant” newspapers, “Itogi” magazine, etc.
STEP 3: First-in-Russia educational workshops on Pharmacometrics and Model-based Drug Development, Oct 2013
STEP 4: M&S Decisions granted Skolkovo residency status and became a core partner in a newly created Biostatistics & Modeling group at the Healthcare Research Center directly affiliated with the Russian Ministry of Health, Dec 2015
STEP 5: In close collaboration with Skolkovo foundation M&S Decisions organized a conference dedicated to the regulatory aspects of the original drug registration within the various health authorities, June 2016.
STEP 6: Together with the Skolkovo foundation and the Open Skolkovo University M&S Decisions organized annual school on Modeling sciences in Drug Development, Dec 2016.
STEP 7: M&S Decisions team develops and grows a large network of functional relations within Russian scientific community. This provides us a unique opportunity to use the advanced modeling techniques for the client project needs.